STOCK TITAN

Oculis Publishes Invitation to the Annual General Meeting

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Oculis Holding AG has published an invitation to its 2024 Annual General Meeting, scheduled for May 29, 2024, in Zug, Switzerland. The meeting details and materials are available on the company's website.

Positive
  • None.
Negative
  • None.

Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on 29 May 2024 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland, at 3:30 p.m. CEST / 9:30 a.m. EDT.

All information pertaining to the 2024 Annual General Meeting, including meeting materials, can be accessed on the Oculis website at https://investors.oculis.com/events-presentations.

About Oculis

Oculis is a global biopharmaceutical company (Nasdaq: OCS) purposefully driven to save sight and improve eye care. Oculis’ highly differentiated pipeline comprises multiple innovative product candidates in development. It includes OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the treatment of inflammation and pain following cataract surgery; OCS-02 (licaminlimab), a topical biologic anti-TNFα eye drop candidate for dry eye disease (DED) and for non-infectious anterior uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. Headquartered in Switzerland and with operations in the U.S. and Iceland, Oculis’ goal is to deliver life-changing treatments to patients worldwide. The company is led by an experienced management team with a successful track record and is supported by leading international healthcare investors.

For more information, please visit: www.oculis.com

Oculis Contacts

Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com

Investor & Media Relations

LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com
1-212-915-2577


FAQ

When is Oculis Holding AG's 2024 Annual General Meeting?

The 2024 Annual General Meeting of Oculis Holding AG is scheduled for May 29, 2024.

Where will the 2024 Annual General Meeting of Oculis Holding AG be held?

The meeting will take place at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, Switzerland.

What time will the 2024 Annual General Meeting of Oculis Holding AG start?

The meeting is set to begin at 3:30 p.m. CEST / 9:30 a.m. EDT.

Where can I access information and meeting materials for the 2024 Annual General Meeting?

All details regarding the meeting, including materials, can be found on the Oculis website at https://investors.oculis.com/events-presentations.

Oculis Holding AG Ordinary shares

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Stock Data

616.19M
38.73M
7.23%
31.8%
0.04%
Biotechnology
Healthcare
Link
United States of America
Zug